Mustang Bio (MBIO) Net Cash Flow (2016 - 2026)

Mustang Bio (MBIO) has reported Net Cash Flow for 11 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 29.61% year-over-year to -$1.1 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 68.89% decrease from a year earlier, with the FY2025 full-year figure at $10.4 million, up 7291.03% from the prior year.
• Net Cash Flow was -$1.1 million for Q2 2026 at Mustang Bio, down from -$1.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $12.6 million in Q1 2022 and troughed at -$42.7 million in Q2 2023.
• A 5-year average of -$5.3 million and a median of -$1.6 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow slumped 2789.67% in 2022 and jumped 951.55% in 2025, its largest moves.
• Over 5 years, Net Cash Flow stood at -$15.7 million in 2022, then jumped by 78.81% to -$3.3 million in 2023, then surged by 188.31% to $2.9 million in 2024, then slumped by 158.46% to -$1.7 million in 2025, then soared by 35.51% to -$1.1 million in 2026.
• The last three Net Cash Flow figures came in at -$1.1 million (Q2 2026), -$1.0 million (Q1 2026), and -$1.7 million (Q4 2025), per Business Quant data.